Neupogen 30 MIU - USA (Filgrastim Syringe) 150mcg/0.5ml

Neupogen 30 MIU (Filgrastim) in syringe form at 150mcg/0.5ml is a prescription biologic used to support white blood cell production. This USA-sourced injectable helps reduce infection risk during chemotherapy. Filgrastim syringe 150mcg/0.5ml is commonly prescribed for neutropenia management.

Strength

150mcg/0.5ml

Pack Size

Manufacturer / TM Owner

Amgen USA

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Filgrastim syringe 150mcg/0.5ml is used to treat neutropenia, a low white blood cell count often caused by chemotherapy. It helps the body make more neutrophils, reducing infection risk during cancer treatment. This medication is also used before stem cell transplants to help stem cells move from the bone marrow into the bloodstream. Patients with severe chronic neutropenia may also receive filgrastim to maintain healthy white blood cell levels.

Side Effects

Filgrastim works by stimulating the bone marrow to produce more white blood cells, particularly neutrophils. Patients may notice improved energy levels as their immune function stabilizes. Some experience mild bone or muscle pain as the bone marrow responds to the medication. These effects are generally temporary and tied to the body’s adjustment period.

Precautions & Warnings

Keep filgrastim syringes refrigerated but avoid freezing. Do not shake the syringe; gentle rolling between palms is recommended if needed. Discard any unused portion left in the syringe after use. Always follow healthcare provider instructions for proper injection technique and disposal. Report any signs of allergic reaction immediately.

Avoid Interactions

Filgrastim may interact with chemotherapy drugs, especially those given at the same time, which can reduce its effectiveness. Avoid live vaccines while using filgrastim due to potential immune system interference. Some medications, like lithium, may enhance filgrastim’s effects. Always inform your healthcare provider about all medications and supplements being used.

References

Frequently Asked Questions

It is used to increase white blood cell counts in patients with neutropenia, often due to chemotherapy or other conditions.

Store refrigerated between 2°C and 8°C (36°F and 46°F); do not freeze or shake.

Common effects include bone or muscle pain, which are usually temporary and related to the medication’s action.

It is prescribed alongside chemotherapy to reduce infection risk but should be used under medical supervision.

It is given as an injection, typically under the skin or into a vein, as directed by a healthcare provider.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.